Viewing Study NCT07284758


Ignite Creation Date: 2025-12-25 @ 12:11 AM
Ignite Modification Date: 2026-05-26 @ 1:05 AM
Study NCT ID: NCT07284758
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-12-16
First Post: 2025-12-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma
Sponsor: C4 Therapeutics, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Multiple Myeloma View
None Relapsed/Refractory Multiple Myeloma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None cemsidomide View
None dexamethasone View
None Multiple Myeloma View